GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New brain cancer drug enters human testing
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink or stabilize tumors and is safe for patients. Participants will receive the drug…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill aims to extend life for deadly brain cancer patients
Disease control Not yet recruitingThis study is testing if adding a new oral medication called NG101m to the standard treatment helps people with newly diagnosed glioblastoma, a serious brain cancer, live longer. All participants will take NG101m capsules along with their usual chemotherapy and radiation. The mai…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC